Treatment-resistant depression: mouse study reveals surprising new insights
January 29, 2024 - Dr. Paul Albert’s team found that not one, but two systems of neurotransmitters play a key role in mouse models of treatment-resistant depression. |
The Ottawa Hospital awarded nine grants worth $5.6 million from Canadian Institutes of Health Research
February 3, 2020 - How can we treat depression when nothing else is working? How can heart growth be both good and bad? How can we increase patient participation in clinical trials? These are just a few of the big questions that researchers at The Ottawa Hospital ... |
How a lucky accident helped spark a new era of depression research
October 21, 2019 - It all started with one lucky accident. In the late 1980’s, Dr. Paul Albert was trying to isolate a gene that controls metabolism. Instead, he pulled out a gene that controls motivation and another that controls mood. These two genes became the ... |
Depression linked to “junk DNA” in the serotonin receptor gene
November 21, 2018 - The human genome is thought to be 75 to 90 percent meaningless “junk DNA”, but researchers are increasingly finding that some of this junk may actually do something important. For example, new research led by Dr. Paul Albert and Dr. Eitan ... |
Researchers awarded $1.7 M to tackle stroke and heart attack from multiple angles
October 2, 2018 - Five groups from The Ottawa Hospital, affiliated with the University of Ottawa, were successful in the Heart and Stroke Foundation's recent grant competition. Drs. Dar Dowlatshahi, Tim Ramsay and Elizabeth Rochon were awarded $290,000* to test ... |
Freud-1 gene lives up to its name
March 14, 2018 - When Dr. Paul Albert coined the name “Freud-1” for a novel gene he discovered in 2003, he had high hopes that it would prove to be important in mental health, just as Sigmund Freud’s theories were. Over the last 15 years, Dr. Albert and his team ha |
Antidepressants and exercise in stroke recovery: surprising results from new mouse study
March 2, 2018 - Exercise and selective serotonin reuptake inhibitors (SSRIs) are effective in treating certain kinds of depression, but little research has tested them together in post-stroke depression, which affects 20 to 80 percent of stroke survivors. Drs. Pau |
Dr. Paul Albert recognized for ground-breaking discoveries in mental health
July 11, 2017 - Dr. Paul Albert has received the top research award from the Canadian College of Neuropsychopharmacology (the Heinz Lehmann Award) for his “outstanding and innovative research” in mental health.
Nearly 30 years ago, Dr. Albert performed the fir |
New model may lead to better treatments for depression after stroke
September 14, 2016 - Dr. Paul Albert and his team have developed a new animal model to help test treatments for depression after stroke. Between 20 to 80 percent of stroke patients will be diagnosed with depression, which greatly impacts both their quality of life an |
Novel therapy seeks to bring light to post-stroke depression
July 7, 2015 - An innovative technique that uses light to turn on or off cells in the brain holds “tremendous promise” in the treatment of severe anxiety and depression after stroke, says Dr. Paul Albert, a professor at the University of Ottawa and senior scientist |
Ottawa stroke researchers awarded nearly $500,000
June 17, 2015 - The HSF Canadian Partnership for Stroke Recovery has awarded nearly $500,000 for a number of stroke research projects in Ottawa. Dr. Paul Albert had the top-ranked grant in the competition (and won the Dr. Tony Hakim Stroke Research Award) for his pr |
